Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1991-2-14
|
pubmed:abstractText |
Direct intralymphatic administration of radiolabeled monoclonal antibody in targeting antigen-bearing lymphoma cells in regional lymph nodes of patients with cutaneous T-cell lymphoma was evaluated. Seven consecutive patients undergoing staging lymphangiography received intralymphatic infusions of 111In-T101 to evaluate lymph node involvement. This procedure was accomplished without significant complication. The 111In-T101 rapidly distributed throughout the regional lymphatic compartment and passed into the systemic circulation. Tumor-bearing sites in the inguinal-femoral lymph nodes retained from 0.42 to 4.8% of the injected dose of radiolabeled antibody. Three patients were upstaged to Stage IVA based on tumor involvement found after radiolymphoscintigraphy-directed biopsy of groin lymph nodes, selected because of intense radioactivity by gamma camera imaging. Compared with previously reported s.c. antibody administration, there was a marked reduction in the radioactive exposure of normal tissues at the injection sites in the lower extremities. Direct intralymphatic delivery of 111In-T101 appears to be a feasible, efficient method for delivering therapeutic doses of radiolabeled antibody.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
688-95
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1985786-Adult,
pubmed-meshheading:1985786-Aged,
pubmed-meshheading:1985786-Antibodies, Monoclonal,
pubmed-meshheading:1985786-Female,
pubmed-meshheading:1985786-Humans,
pubmed-meshheading:1985786-Indium Radioisotopes,
pubmed-meshheading:1985786-Injections,
pubmed-meshheading:1985786-Injections, Subcutaneous,
pubmed-meshheading:1985786-Lymph Nodes,
pubmed-meshheading:1985786-Lymphoma,
pubmed-meshheading:1985786-Male,
pubmed-meshheading:1985786-Middle Aged,
pubmed-meshheading:1985786-Skin Neoplasms
|
pubmed:year |
1991
|
pubmed:articleTitle |
Direct intralymphatic injection of radiolabeled 111In-T101 in patients with cutaneous T-cell lymphoma.
|
pubmed:affiliation |
National Cancer Institute, NCI-Navy Medical Oncology Branch, Naval Hospital, Bethesda, MD 20814.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|